World Wires · story 100649 · corroborated · 1 source(s)

LG Chem amends obesity drug licensing deal with Rhythm Pharmaceuticals

LG Chem increased the total value of its licensing agreement with Rhythm Pharmaceuticals for an obesity treatment to $855 million.

Open in the desk

Coverage

• LG Chem amends obesity drug licensing deal with Rhythm Pharmaceuticals Yonhap News (Korea) · tier B · clear net · 2026-11-03 05:42 UTC

What this site indexes